Celldex Therapeutics (CLDX) Q1 2019 Earnings

7MarConfirmed
Q2 2018
Q3 2018
Q4 2018
Q1 2019
-2.83
-2.09
-1.34
-0.6

Details

Expected EPS
-1.2
Actual EPS
-0.81
Surprise EPS
0.39
Surprise Percent
+32.5%

Description

Celldex Therapeutics (CLDX) has reported earnings of -0.81 per share for Q1 2019.

0 Comments

Share your thoughts